Literature DB >> 636907

Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states.

L H Lindström, E Widerlöv, L M Gunne, A Wahlström, L Terenius.   

Abstract

The significance of endorphins, endogenous morphine-like agents, in some psychiatric disorders was investigated. Samples of cerebrospinal fluid were taken by lumbar puncture from healthy volunteers and from patients with schizophrenic, manic-depressive and puerperal psychosis and analyzed for two major fractions of endorphins (Fractions I and II). In 19 healthy volunteers the levels of the two fractions fell within a fairly narrow range. In contrast, six out of nine drug-free and symptom-rich schizophrenics showed elevated levels of Fraction I, which returned to normal or slightly supranormal values after treatment with neuroleptics or propranolol. This decrement was paralleled by a clinical improvement in four of six responding patients. In four manic-depressive patients, serial samples of cerebrospinal fluid revealed elevated endorphin levels, particularly Fraction I during the manic stage. In three out of four patients with puerperal psychosis, the levels of endorphins (either Fraction I or II) were elevated in the acute drug-free stage. During a later symptom-free stage, after treatment with ECT and/or neuroleptics, the endorphin levels were within the normal range. The present data lend credit to the hypothesis that endorphins are involved in some psychotic states in the human.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 636907     DOI: 10.1111/j.1600-0447.1978.tb06883.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

Review 1.  Effects of exercise and physical activity on depression.

Authors:  P C Dinas; Y Koutedakis; A D Flouris
Journal:  Ir J Med Sci       Date:  2010-11-14       Impact factor: 1.568

2.  Acupuncture: a useful treatment modality.

Authors:  L M Rapson
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

3.  Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients.

Authors:  B G Almay; F Johansson; L von Knorring; G Sedvall; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

4.  Clozapine inhibition of metenkephalin binding to synaptosome-enriched fractions of rat whole brain and hippocampus.

Authors:  E Somoza; C Franco; M Laviña; J A Fuentes
Journal:  Neurochem Res       Date:  1981-04       Impact factor: 3.996

5.  Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.

Authors:  R Weizman; A Weizman; S Tyano; G Szekely; B A Weissman; Y Sarne
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 6.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

7.  The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.

Authors:  A Weizman; I Gil-Ad; D Grupper; S Tyano; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  New and experimental therapeutic roles for naloxone and related opioid antagonists.

Authors:  L F McNicholas; W R Martin
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

Review 9.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.